Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Reviving Hope for Amblyopia: Late-Stage Treatment
In children with amblyopia, often referred to as “lazy eye,” one eye exhibits weaker vision than the other due to various factors. This weaker eye may struggle with focusing, misalignment due to strabismus, or vision obstruction from conditions like cataracts…
Scientists Innovate Tech for Ischemic Retinopathy Treatment
Professor Byoung Heon Kang and his research team at the Department of Biological Sciences at Ulsan National Institute of Science and Technology (UNIST), in collaboration with Professor Dong Ho Park’s team at Kyungpook National University Hospital, have developed a novel…
UCL-Moorfields Eye Hospital Secures £5M for Research Center
The Sir Jules Thorn Charitable Trust has allocated £5 million towards the establishment of a research center within Oriel, the collaborative initiative between UCL and Moorfields Eye Hospital aimed at advancing eye health. Partnering with Moorfields Eye Charity and Moorfields…
Australian Government Funds $35M Cornea Facility
The Australian Government is making significant strides in the global fight against blindness by allocating funds for the establishment of a state-of-the-art manufacturing facility for artificial corneas. The University of Sydney has been designated to receive $35 million through the…
New Experimental Drug Shows Promise in Treating DME
A recent study published in Nature Medicine has unveiled promising insights into a potential breakthrough in the treatment of Diabetic Macular Edema (DME). The study suggests that an experimental drug, part of a new class of therapeutics called “senolytics,” could…
Four OUWB students successful in 2024 early match for ophthalmology – Oakland University
Four OUWB students successful in 2024 early match for ophthalmology Oakland University Source: Author: | Date: 2024-02-07 08:00:00 Source: Author: | Date: 2024-02-07 08:00:00
Toku Granted CE and UKCA Marks for CLAiR Technology
Toku announced the acquisition of the CE Mark in Europe and UKCA certification in the United Kingdom for its patented CLAiR technology. This innovation offers a non-invasive method for assessing the risk of cardiovascular disease (CVD) directly at the point…
Iridex Granted European Patent for MicroPulse Technology
Iridex, a pioneering company in the field of medical devices, announced the grant of the European Patent ‘EP 3009093.’ This patent, titled “Laser System with Short Pulse Characteristics and its Methods of Use,” signifies a significant milestone for the company,…
Negative Effect of Atropine Drops After Glaucoma Surgery
According to a report by an international team of researchers, atropine instillation after trabeculectomy should be discouraged since it causes greater and longer lasting reduction in visual quality.1 The study’s lead author is Panagiotis Laspas, MD, of the Department of…
Perfluorohexyloctane Drops Help Alleviate Dry Eye
According to recent research, perfluorohexyloctane eye drops (SHR8058) demonstrated significant improvement in both the signs and symptoms of dry eye disease (DED) linked to meibomian gland dysfunction (MGD) with rapid effectiveness in Chinese patients. The findings showed that the perfluorohexyloctane…